News | Heart Failure | June 20, 2022

Memorial Cardiac and Vascular Institute is First in South Florida to Use ‘Harmony’ for Valve Replacement

Memorial Cardiac and Vascular Institute is First in South Florida to Use ‘Harmony’ for Valve Replacement

June 20, 2022— Marc Chatzky may not feel like a cardiac pioneer, but he is, at least in South Florida. The Deerfield Beach resident was the first to have a defective pulmonary valve replaced without open-heart surgery, instead using a minimally-invasive transcatheter procedure and the recently-approved Harmony™ valve. 

The approach, which enabled Chatzky to avoid the pain and extended recovery time of an open-heart surgery, was done in the Memorial Cardiac and Vascular Institute’s cardiac catheterization lab. It involved inserting the Harmony valve into the heart via a tube fed through a vein in the groin, with the device expanding to a shape and size that fit Chatzky’s heart after placement, a marked improvement over traditional-sized valves. 

“Once we’ve determined that the patient meets criteria that a pulmonary valve is necessary, we go through a series of testing to make sure that the Harmony valve is appropriate for that patient’s anatomy,” Roth said. “Our being the first in the region to do this procedure speaks to our innovation as a center of excellence for adult congenital heart disease care.” 

For Chatzky, who had several open-heart surgeries as a child to correct congenital heart issues, the new approach fit his current lifestyle. He was back on his feet the day after the procedure and back to work shortly after. “It was better than being out for maybe six months and I was quickly back to doing normal things. Now my bosses are trying to slow me down because I’m working too much,” Chatzky joked. 

The procedure was completed by a team led by the co-medical directors of Memorial’s Adult Congenital Heart Disease program, Drs. Todd Roth and Larry Latson, with an assist from Dr. Tom Forbes and Dr. Peter Guyon, interventional cardiologists at Joe DiMaggio Children’s Hospital. 

For Chatzky, who had been experiencing chest pain and whose heart was actively failing him, the procedure was just what the patient ordered. 

 

For more information: www.memorialcardiaccare.com 


Related Content

News | Heart Failure

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...

Home October 28, 2025
Home
News | Heart Failure

Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...

Home October 16, 2025
Home
News | Heart Failure

Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...

Home September 24, 2025
Home
News | Heart Failure

Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) ...

Home September 22, 2025
Home
News | Heart Failure

Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...

Home September 15, 2025
Home
News | Heart Failure

Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...

Home August 15, 2025
Home
News | Heart Failure

Aug. 6, 2025 — Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...

Home August 06, 2025
Home
News | Heart Failure

July 14, 2025 — Bayer has announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA (finerenone) to ...

Home July 14, 2025
Home
News | Heart Failure

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...

Home June 25, 2025
Home
News | Heart Failure

June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...

Home June 04, 2025
Home
Subscribe Now